Skip to content

Selective serotonin reuptake inhibitor(SSRI) induced sexual dysfunction in female patients and its effect on quality of life.

A STUDY OF SEXUAL DYSFUNCTION AND QUALITY OF LIFE IN FEMALE PATIENTS ON SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/013248
Enrollment
100
Registered
2018-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- female patients on SSRIs at least for 06 weeks visiting Psychiatry OPD in tertiary care hospital Health Condition 2: F328- Other depressive episodes

Interventions

Sponsors

Govt Medical College Bhavnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients will be included who are sexually active. Patient on treatment with SSRIs for at least 06 weeks will be included. Patients who will be willing to discuss her sexual functioning with the Doctor and give informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Pregnant or Lactating women. Any medical/surgical illness or disease which can cause sexual dysfunction. Those suffering from any psychiatric disorder other than depression and anxiety. Patient who will not be ready to discuss her sexual functioning and give informed consent.

Design outcomes

Primary

MeasureTime frame
To Study the frequency of Sexual Dysfunction in Female patients on treatment with SSRI for Depression and Anxiety. To Study association of Quality of Life with Sexual Dysfunction in Female patients on treatment with SSRI. To Study the severity of Sexual Dysfunction with Depression and Anxiety in Female patients on treatment with SSRIs. Timepoint: Total duration of study was six months. Outcome was assessed after six months of the starting study.

Secondary

MeasureTime frame
To Study association of Quality of Life with Depression and Anxiety in Female patients on treatment with SSRIs. Timepoint: Total duration of study was six months. Outcome was assessed after six months of the starting study.

Countries

India

Contacts

Public ContactDr Bharat N Panchal

Govt. Medical College, Bhavnagar

drbnpanchal@rediffmail.com9427558894

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026